SPACs in the Healthcare Sector: Structuring Transactions, Considerations and Challenges for Companies, Investors
Recording of a 90-minute CLE video webinar with Q&A
This CLE course will guide healthcare counsel on special purpose acquisition companies (SPACs). The panel will examine SPAC formation and structuring. The panel will discuss the benefits and considerations for both private and public companies. The panel will also discuss challenges for the parties involved and offer best practices for structuring SPAC IPOs.
Outline
- Recent developments of SPACs in healthcare
- Overview of SPACs and key features
- Structuring considerations and issues of concern
- Private company considerations
- Public company considerations
- Sponsor considerations
- Best practices for counsel, sponsors, and sellers
Benefits
The panel will review these and other key issues:
- What factors should be considered when determining the structure of SPACs in the healthcare industry?
- How do the incentives created under SPACs differ for the sponsor and the investors?
- What are the potential tax consequences to investors?
Faculty
Michael A. Smith
Partner
Nixon Peabody
Mr. Smith has more than 25 years of experience advising international and domestic companies on global capital markets... | Read More
Mr. Smith has more than 25 years of experience advising international and domestic companies on global capital markets and U.S. securities law, cross-border M&A transactions, international fund formation, and Shariah finance. He advises public and private companies in M&As with significant cross-border experience, advising on transactions into and out of the U.S., Canada, Europe, the Middle East, North Africa, sub-Saharan Africa, Latin America, and China. With deep experience across a wide range of industries, including financial services, healthcare, life sciences, and oil and gas, Mr. Smith has developed a focus in the cannabis space in recent years. He is also active in the use of special-purpose acquisition companies (SPACs) by private equity firms to raise assets under management.
Close
John R. Washlick
Shareholder
Buchanan Ingersoll & Rooney
Mr. Washlick is a recognized authority on federal income tax issues involving tax-exempt organizations and the... | Read More
Mr. Washlick is a recognized authority on federal income tax issues involving tax-exempt organizations and the Anti-Kickback Statute and the Stark Law. His guidance is often sought as his clients assess various arrangements with physicians, such as clinical joint ventures, co-management arrangements, integrated delivery systems, business joint ventures, physician recruitment, practice acquisitions, employment arrangements, hospital/physician integration planning and exclusive provider agreements. Mr. Washlick also advises healthcare industry clients, including entrepreneurs and investment-backed entities on general corporate law and regulatory healthcare-related issues, such as the corporate practice of medicine and fee splitting laws. He has experience in structuring, negotiating and documenting a variety of complex business transactions, including mergers and acquisitions, joint operating agreements, joint ventures, clinical co-management agreements, academic and clinical affiliations, and contractual relationships among providers and with third-party payors. Mr. Washlick advises clients in the formation or acquisition of new entities, the restructuring of existing entities and the creation of alliances or other integration initiatives. Mr. Washlick speaks and writes on transaction, governance, regulatory and compliance matters, and he has been published in many healthcare and tax-related publications.
Close